Krohne, Tim U <br/><br/>
Influence of ocular volume and lens status on pharmacokinetics and duration of action of intravitreal vascular endothelial growth factor inhibitors.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Jan 2015 
 - 69-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1539-2864 
<br/><br/><label>Standard No.: </label>10.1097/IAE.0000000000000265  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacokinetics<br/>Antibodies, Monoclonal, Humanized--pharmacokinetics<br/>Aqueous Humor--metabolism<br/>Axial Length, Eye--anatomy & histology<br/>Bevacizumab<br/>Biological Availability<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Intravitreal Injections<br/>Lens, Crystalline--physiology<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>Ranibizumab<br/>Refraction, Ocular--physiology<br/>Retinal Diseases--drug therapy<br/>Retinal Vein Occlusion--drug therapy<br/>Time Factors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Wet Macular Degeneration--drug therapy